Antibody response

#Antibody response #Biologics #Drug targets #Novel therapeutics #RNA #siRNA

Sitting down with…Michael Smyth, Galapagos UK

Michael Smyth is Medical Director at Galapagos UK, responsible for launching innovative therapies in the UK to help change the course of inflammatory disease for patients. Having studied medicine at Liverpool University, one of his personal missions is lifelong learning which is reflected in his role to strive for new treatment… Read More

#Editor's Choice #News #Opinion